Physiomics Plc (PYC) - Cash Flow Conversion Efficiency

Latest as of December 2025: -0.514x

Based on the latest financial reports, Physiomics Plc (PYC) has a cash flow conversion efficiency ratio of -0.514x as of December 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (GBX-202.00K ≈ $-24.58 USD) by net assets (GBX393.00K ≈ $47.82 USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see Physiomics Plc stock valuation for the company's overall valuation and market capitalisation.

Physiomics Plc - Cash Flow Conversion Efficiency Trend (2001–2025)

This chart illustrates how Physiomics Plc's cash flow conversion efficiency has evolved over time, based on yearly financial data.

Physiomics Plc Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Physiomics Plc ranked by their cash flow conversion efficiency. Explore Physiomics Plc cash earnings quality to measure how well operating cash flow supports reported net income.

Company	Cash Flow Conversion Efficiency
Chordate Medical Holding AB ST:CMH	-0.514x
FAT Brands Inc NASDAQ:FATBW	0.050x
Carisma Therapeutics Inc. NASDAQ:CARM	-2.201x
t42 IoT Tracking Solutions PLC LSE:TRAC	-0.185x
Anemoi International Ltd LSE:AMOI	-0.089x
WICKET GAMING AB F:7Q4	0.015x
Sonder Holdings Inc NASDAQ:SOND	0.040x
Gaming Technologies Inc. Common Stock NASDAQ:GMGT	0.110x

Annual Cash Flow Conversion Efficiency for Physiomics Plc (2001–2025)

The table below shows the annual cash flow conversion efficiency of Physiomics Plc from 2001 to 2025. View latest Physiomics Plc stock price today for real-time trading data and today's change.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2025-06-30	GBX692.17K ≈ $84.22	GBX-546.14K ≈ $-66.45	-0.789x	+59.33%
2024-06-30	GBX282.53K ≈ $34.38	GBX-548.13K ≈ $-66.69	-1.940x	-289.48%
2023-06-30	GBX531.72K ≈ $64.69	GBX-264.86K ≈ $-32.23	-0.498x	-39.03%
2022-06-30	GBX974.81K ≈ $118.61	GBX-349.25K ≈ $-42.49	-0.358x	-1185.23%
2021-06-30	GBX1.17 Million ≈ $141.83	GBX-32.50K ≈ $-3.95	-0.028x	+68.31%
2020-06-30	GBX1.31 Million ≈ $160.00	GBX-115.69K ≈ $-14.08	-0.088x	+62.80%
2019-06-30	GBX607.91K ≈ $73.97	GBX-143.77K ≈ $-17.49	-0.237x	+3.89%
2018-06-30	GBX690.03K ≈ $83.96	GBX-169.80K ≈ $-20.66	-0.246x	+81.53%
2017-06-30	GBX328.25K ≈ $39.94	GBX-437.27K ≈ $-53.20	-1.332x	+21.60%
2016-06-30	GBX204.15K ≈ $24.84	GBX-346.87K ≈ $-42.20	-1.699x	-40.90%
2015-06-30	GBX325.62K ≈ $39.62	GBX-392.65K ≈ $-47.77	-1.206x	+53.18%
2014-06-30	GBX136.49K ≈ $16.61	GBX-351.51K ≈ $-42.77	-2.575x	-25.62%
2013-06-30	GBX255.82K ≈ $31.13	GBX-524.49K ≈ $-63.81	-2.050x	-172.94%
2012-06-30	GBX734.57K ≈ $89.38	GBX-551.77K ≈ $-67.13	-0.751x	+11.68%
2011-06-30	GBX756.00K ≈ $91.98	GBX-643.00K ≈ $-78.23	-0.851x	-54.23%
2010-06-30	GBX787.00K ≈ $95.76	GBX-434.00K ≈ $-52.81	-0.551x	-80.29%
2009-06-30	GBX-85.00K ≈ $-10.34	GBX26.00K ≈ $3.16	-0.306x	-188.03%
2008-06-30	GBX-354.00K ≈ $-43.07	GBX-123.00K ≈ $-14.97	0.347x	+108.89%
2007-06-30	GBX99.00K ≈ $12.05	GBX-387.00K ≈ $-47.09	-3.909x	-194.51%
2006-06-30	GBX-66.00K ≈ $-8.03	GBX-273.00K ≈ $-33.22	4.136x	+499.14%
2005-06-30	GBX413.00K ≈ $50.25	GBX-428.00K ≈ $-52.08	-1.036x	-268.28%
2004-06-30	GBX-354.00K ≈ $-43.07	GBX-218.00K ≈ $-26.52	0.616x	-60.87%
2003-06-30	GBX-129.00K ≈ $-15.70	GBX-203.00K ≈ $-24.70	1.574x	+233.71%
2001-06-30	GBX130.00K ≈ $15.82	GBX-153.00K ≈ $-18.62	-1.177x	--

About Physiomics Plc

LSE:PYC UK Biotechnology

Market Cap

$28.95K

GBX237.93 Million GBX

Market Cap Rank

#31710 Global

#1248 in UK

Share Price

GBX0.53

Change (1 day)

+0.00%

52-Week Range

GBX0.27 - GBX0.70

All Time High

GBX17.13